Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(24 sites)

Belgium

BE-Antwerpen-ZNASTUIVENBERG, Antwerp

BE-Roeselare-AZDELTA, Roeselare

Denmark

DK-Aalborg-ALBOGUH, Aalborg

DK-Copenhagen-RIGSHOSPITALET, Copenhagen

DK-Odense-OUH, Odense

Germany

DE-Berlin-HELIOSBERLINBUCH, Berlin

DE-Köln-UKKOELN, Cologne

DE-Freiburg-UNIKLINIKFREIBURG, Freiburg im Breisgau

DE-Greifswald-UNIGREIFSWALD, Greifswald

DE-Munster-GEMEINSCHAFTSPRAXIS, Münster

DE-Stuttgart-RBK, Stuttgart

DE-Ulm-UNIKLINKULM, Ulm

Netherlands

NL-Den Bosch-JBZ, 's-Hertogenbosch

NL-Alkmaar-NWZ, Alkmaar

NL-Amersfoort-MEANDERMC, Amersfoort

NL-Amsterdam-AMC, Amsterdam

NL-Dordrecht-ASZ, Dordrecht

NL-Ede-ZGV, Ede

NL-Eindhoven-CATHARINA, Eindhoven

NL-Groningen-UMCG, Groningen

NL-Leeuwarden-MCL, Leeuwarden

NL-Den Haag-HAGA, The Hague

NL-Tilburg-ETZ, Tilburg

NL-Utrecht-UMCUTRECHT, Utrecht